MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Rigidity"

  • 2018 International Congress

    Recruitment of Minority populations with Parkinson’s disease at an Urban Hospital

    C. Branson, S. Bissonette, T. Johnson, J. Weinberg, M. Saint-Hilaire (Boston, MA, USA)

    Objective: To evaluate diagnostic disparities in Parkinson’s disease (PD) through recruitment of underrepresented minorities into a PD screening study. Background: African-Americans are less likely than…
  • 2017 International Congress

    Do motor symptoms influence on malnutrition in Parkinson`s disease patients?

    S. Tomic, V. Pekic, Z. Popijac, T. Pucic, M. Petek, T. Gilman Kuric (Osijek, Croatia)

    Objective: The aim of this study was to determine the prevalence of malnutrition and to analyze influence of age, sex, disease duration and motor symptoms…
  • 2017 International Congress

    The FDA is listening: Integrating the voice of the patient in drug development for Parkinson’s and Huntington’s diseases.

    D. Stephenson, A. Porter, K. Romero, G. Podskalny, E. Bastings, B. Dunn, S. Goldstein, T. Mullin (Tucson, AZ, USA)

    Objective: To present highlights from the Patient-Focused Drug Development (PFDD) meetings held at FDA for Parkinson’s disease (PD) and Huntington’s disease (HD) to raise awareness…
  • 2017 International Congress

    Increased and symmetric expression of rigidity in early Parkinson’s disease with abnormal REM sleep without atonia

    M. Petrucci, S. Amundsen Huffmaster, C. Lu, P. Tuite, M. Howell, C. MacKinnon (Minneapolis, MN, USA)

    Objective: The purpose of this study was to compare the level and bilateral expression of upper arm rigidity between people with early stage Parkinson’s disease…
  • 2017 International Congress

    Assessing Parkinson’s disease motor symptoms using supervised learning algorithms

    P. Angeles, Y. Tai, N. Pavese, R. Vaidyanathan (London, United Kingdom)

    Objective: Implantable brain stimulators are now an established method of treating Parkinson’s Disease (PD). Determination of optimal neural stimulation parameters is complex and clinically demanding. The goal of…
  • 2017 International Congress

    Objective biomarkers of posture balance for early and advanced Parkinson’s disease

    I. Miliukhina, E. Gracheva, A. Kudrevatykh, T. Sergeev, M. Didur (Saint-Petersburg, Russian Federation)

    Objective: The aim of this study was to investigate the postural performance of patients with early and advanced Parkinson's disease (PD) using computerized posturography. Background:…
  • 2016 International Congress

    Sleep related disorders in subtypes of patients with Parkinson’s disease in the Tomsk region, Russia

    M.A. Nikitina, I.A. Zhukova, V.M. Alifirova, N.G. Zhukova, O.P. Izhboldina, J.S. Mironova, M.A. Titova, N.G. Brazovskaya, S.E. Sukhanov (Tomsk, Russia)

    Objective: To describe sleep related disorders (SRD) in Tremor Dominant (TD) and Akinetic Rigid (AR) patients with Parkinson's disease in (PwPD) subtypes evaluated at Movement…
  • 2016 International Congress

    Incidence of fragility fractures in people with parkinsonism [PwP] – A 5 year retrospective observational study

    S. Aithal, C. Thomas, S. Raha, H. Shukla, L. Ebenezer, R. Sequeria, B. Mohamed (Caerphilly, United Kingdom)

    Objective: The objective of this study is to estimate the incidence of fragility fractures in people with Parkinson's (PwP) over a 5 year period and…
  • 2016 International Congress

    Diagnostic reliability of clinical symptoms in patients with incomplete manifestation of the triad of parkinsonism compared to 18F-DOPA PET-CT MRI imaging

    C. Peralta, T. Soto Depetris, A. Perez, F. Biafore, J. Gili, A. Valda, D. Menna, M. Aguilar, H. Corradini, M. Bastianello (Caba, Argentina)

    Objective: To describe the diagnostic reliability of the triad of clinical symptoms compared to the uptake of 18 F-DOPA PET-CT fusion MRI scan. To compare…
  • 2016 International Congress

    Are clinical certainty ratings helpful in the diagnosis of Parkinson’s disease?

    H.V. Gupta, S.H. Mehta, J.G. Hentz, H.A. Shill, E. Driver-Dunckley, M.N. Sabbagh, C.M. Belden, B.N. Dugger, T.G. Beach, G.E. Serrano, L.I. Sue, C.H. Adler (Scottsdale, AZ, USA)

    Objective: To determine whether clinical certainty ratings are helpful in predicting pathologically proven PD. Background: Clinical diagnostic criteria for PD rely on rest tremor, bradykinesia,…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley